These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28105284)

  • 1. Discovery of Novel Seven-Membered Prostacyclin Analogues as Potent and Selective Prostaglandin FP and EP3 Dual Agonists.
    Sugimoto I; Kambe T; Okino T; Obitsu T; Ohta N; Nishiyama T; Kinoshita A; Fujimoto T; Egashira H; Yamane S; Shuto S; Tani K; Maruyama T
    ACS Med Chem Lett; 2017 Jan; 8(1):107-112. PubMed ID: 28105284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of G Protein-Biased EP2 Receptor Agonists.
    Ogawa S; Watanabe T; Sugimoto I; Moriyuki K; Goto Y; Yamane S; Watanabe A; Tsuboi K; Kinoshita A; Kigoshi H; Tani K; Maruyama T
    ACS Med Chem Lett; 2016 Mar; 7(3):306-11. PubMed ID: 26985320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IOP-Lowering Effect of ONO-9054, A Novel Dual Agonist of Prostanoid EP3 and FP Receptors, in Monkeys.
    Yamane S; Karakawa T; Nakayama S; Nagai K; Moriyuki K; Neki S; Suto F; Kambe T; Hirota Y; Kawabata K
    Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2547-52. PubMed ID: 25788650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular hypotensive FP prostaglandin (PG) analogs: PG receptor subtype binding affinities and selectivities, and agonist potencies at FP and other PG receptors in cultured cells.
    Sharif NA; Kelly CR; Crider JY; Williams GW; Xu SX
    J Ocul Pharmacol Ther; 2003 Dec; 19(6):501-15. PubMed ID: 14733708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective Prostacyclin Receptor Agonist Selexipag, in Contrast to Prostacyclin Analogs, Does Not Evoke Paradoxical Vasoconstriction of the Rat Femoral Artery.
    Morrison K; Haag F; Ernst R; Iglarz M; Clozel M
    J Pharmacol Exp Ther; 2018 Jun; 365(3):727-733. PubMed ID: 29588339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal and tissue-specific expression of prostaglandin receptors EP2, EP3, EP4, FP, and cyclooxygenases 1 and 2 in uterus and fetal membranes during bovine pregnancy.
    Arosh JA; Banu SK; Chapdelaine P; Fortier MA
    Endocrinology; 2004 Jan; 145(1):407-17. PubMed ID: 14500566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of a new class of selective EP3 receptor agonist, 13,14-didehydro-16-phenoxy analogues of prostaglandin E1.
    Shimazaki Y; Kameo K; Tanami T; Tanaka H; Ono N; Kiuchi Y; Okamoto S; Sato F; Ichikawa A
    Bioorg Med Chem; 2000 Feb; 8(2):353-62. PubMed ID: 10722158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of postsynaptic EP4 and presynaptic EP3 receptors in actions of prostaglandin E2 in rat supraoptic neurones.
    Shibuya I; Setiadji SV; Ibrahim N; Harayama N; Maruyama T; Ueta Y; Yamashita H
    J Neuroendocrinol; 2002 Jan; 14(1):64-72. PubMed ID: 11903814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of prostaglandin F2 alpha and E receptor mRNA by prostaglandin F 2 alpha in ovine corpora lutea.
    Tsai SJ; Anderson LE; Juengel J; Niswender GD; Wiltbank MC
    J Reprod Fertil; 1998 Sep; 114(1):69-75. PubMed ID: 9875157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data.
    Sharif NA; Xu SX; Williams GW; Crider JY; Griffin BW; Davis TL
    J Pharmacol Exp Ther; 1998 Aug; 286(2):1094-102. PubMed ID: 9694973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct mechanisms regulate induction of messenger ribonucleic acid for prostaglandin (PG) G/H synthase-2, PGE (EP3) receptor, and PGF2 alpha receptor in bovine preovulatory follicles.
    Tsai SJ; Wiltbank MC; Bodensteiner KJ
    Endocrinology; 1996 Aug; 137(8):3348-55. PubMed ID: 8754761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Dual Agonist of EP3 and FP Receptors for OAG and OHT: Safety, Pharmacokinetics, and Pharmacodynamics of ONO-9054 in Healthy Volunteers.
    Suto F; Rowe-Rendleman CL; Ouchi T; Jamil A; Wood A; Ward CL
    Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):7963-70. PubMed ID: 26720443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro characterization of prostanoid receptors on human myometrium at term pregnancy.
    Senior J; Marshall K; Sangha R; Clayton JK
    Br J Pharmacol; 1993 Feb; 108(2):501-6. PubMed ID: 8448599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanisms of enhancement and inhibition of field stimulation responses of guinea-pig vas deferens by prostacyclin analogues.
    Tam FS; Chan K; Borreau JP; Jones RL
    Br J Pharmacol; 1997 Aug; 121(7):1413-21. PubMed ID: 9257922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of prostaglandin analogues on intracellular Ca2+ in ciliary arteries of wild-type and prostanoid receptor-deficient mice.
    Abe S; Watabe H; Takaseki S; Aihara M; Yoshitomi T
    J Ocul Pharmacol Ther; 2013 Feb; 29(1):55-60. PubMed ID: 23046436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin F2α Facilitates Platelet Activation by Acting on Prostaglandin E2 Receptor Subtype EP3 and Thromboxane A2 Receptor TP in Mice.
    Kashiwagi H; Yuhki KI; Imamichi Y; Kojima F; Kumei S; Tasaki Y; Narumiya S; Ushikubi F
    Thromb Haemost; 2019 Aug; 119(8):1311-1320. PubMed ID: 31129913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinase-activated receptor-2 stimulates prostaglandin production in keratinocytes: analysis of prostaglandin receptors on human melanocytes and effects of PGE2 and PGF2alpha on melanocyte dendricity.
    Scott G; Leopardi S; Printup S; Malhi N; Seiberg M; Lapoint R
    J Invest Dermatol; 2004 May; 122(5):1214-24. PubMed ID: 15140225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro pharmacological characterization of the prostanoid receptor population in the non-pregnant porcine myometrium.
    Cao J; Shayibuzhati M; Tajima T; Kitazawa T; Taneike T
    Eur J Pharmacol; 2002 May; 442(1-2):115-23. PubMed ID: 12020689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the prostaglandin E (EP-) receptor subtype mediating relaxation of the rabbit jugular vein.
    Lawrence RA; Jones RL
    Br J Pharmacol; 1992 Apr; 105(4):817-24. PubMed ID: 1324050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of highly potent dual EP(2) and EP(3) agonists with subtype selectivity.
    Kinoshita A; Higashino M; Aratani Y; Kakuuchi A; Matsuya H; Ohmoto K
    Bioorg Med Chem Lett; 2016 Feb; 26(3):1016-1019. PubMed ID: 26725951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.